Skip to main content
. 2023 Aug 18;66(17):12237–12248. doi: 10.1021/acs.jmedchem.3c00810

Figure 5.

Figure 5

Alkyne inhibitors exhibit strong anti-COVID activity and minimal cell toxicity. (A) Anti-SARS-CoV-2 efficacy of the compounds in HeLa-ACE2 cells. (B) Cytotoxicity of the compounds in HeLa-ACE2 cells.